GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
116 hedge funds and large institutions have $1.16B invested in Global Blood Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 41 increasing their positions, 25 reducing their positions, and 19 closing their positions.
Holders
116
Holders Change
+20
Holders Change %
+20.83%
% of All Funds
2.89%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.15%
New
45
Increased
41
Reduced
25
Closed
19
Calls
$19M
Puts
$13.4M
Net Calls
+$5.58M
Net Calls Change
+$5.6M
Top Buyers
1 |
1
BlackRock
New York
|
$96.5M |
2 |
WSC
2
White Square Capital
London,
United Kingdom
|
$53.6M |
3 |
O
3
OrbiMed
New York
|
$40M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$30.9M |
5 |
PA
5
Perceptive Advisors
New York
|
$142M |